Improved vaccines through targeted manipulation of the body's immunological risk‐assessment?
- 20 July 2012
- Vol. 34 (10) , 876-884
Abstract
Recent advances have highlighted the outstanding role of the innate immune system for instructing adaptive immunity. Translating this knowledge into successful immunotherapies like vaccines, however, has proven to be a difficult task. This essay is based on the hypothesis that immune responses are tightly scaled to the infectious threat posed by a given microbial stimulus. A meticulous immunological risk‐assessment process is therefore instrumental for eliciting well‐balanced responses and maintaining immune homeostasis. The immune system makes fine distinctions, for example, between live and dead bacteria, or pathogenic and non‐pathogenic microorganisms. Here, I discuss recent evidence for some of the mechanisms underlying these distinctions and speculate on strategies for therapeutically targeting the immunological risk‐assessment machinery.Keywords
This publication has 74 references indexed in Scilit:
- NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defenseNature Immunology, 2012
- DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic CellsImmunity, 2011
- Activation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’Nature, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteriaNature Immunology, 2010
- Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRsNature Immunology, 2010
- Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?Immunity, 2010
- Patterns of Pathogenesis: Discrimination of Pathogenic and Nonpathogenic Microbes by the Innate Immune SystemCell Host & Microbe, 2009
- Apolipoprotein B Is an Innate Barrier against Invasive Staphylococcus aureus InfectionCell Host & Microbe, 2008
- Recognition of microorganisms and activation of the immune responseNature, 2007